metaCOVID: An R-Shiny application for living meta-analyses of COVID-19 trials
Evrenoglou, T.; Boutron, I.; Chaimani, A.
Show abstract
"Living" evidence synthesis is of primary interest for decision-makers to overcome the COVID-19 pandemic. The COVID-NMA provides open-access living meta-analyses assessing different therapeutic and preventive interventions. Data are posted on a platform (https://covid-nma.com/) and analyses are updated every week. However, guideline developers and other stakeholders also need to investigate the data and perform their own analyses. This requires resources, time, statistical expertise, and software knowledge. To assist them, we created the "metaCOVID" application which, based on automation processes, facilitates the fast exploration of the data and the conduct of analyses tailored to end-users needs. metaCOVID has been created in R and is freely available as an R-Shiny application. The application conducts living meta-analyses for every outcome. Several options are available for subgroup and sensitivity analyses. The results are presented in downloadable forest plots. metaCOVID is freely available from https://covid-nma.com/metacovid/ and the source code from https://github.com/TEvrenoglou/metaCovid.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- The use of the Registered Reports format for publication of randomized clinical trials: a cross-sectional study 95%
- Results reporting for clinical trials led by medical universities and university hospitals in the Nordic countries was often missing or delayed 94%
- Large language models for conducting systematic reviews: on the rise, but not yet ready for use – a scoping review 94%
Similar papers in this journal
- Exploring the potential of Claude 2 for risk of bias assessment: Using a large language model to assess randomized controlled trials with RoB 2 95%
- Evaluation of the sensitivity, accuracy and currency of the Cochrane COVID-19 Study Register for supporting rapid evidence synthesis production 94%
- Fast and frugal decision tree for the rapid critical appraisal of systematic reviews 94%
Similar papers in this journal
- Trials that turn from retrospectively registered to prospectively registered: A cohort study of ‘retroactively prospective’ clinical trial registration using history data 94%
- Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease (CLARITY): Statistical analysis plan for a randomised controlled Bayesian adaptive sample size trial 93%
- Development of a consensus extension of the estimands framework for cluster randomised trials (CRT-estimands): results from an international Delphi study 93%
Similar papers in this journal
- Investigator-initiated versus industry-sponsored trials – Visibility and relevance of randomized controlled trials in clinical practice guidelines (IMPACT) 94%
- Improving research transparency with individualized report cards: A feasibility study in clinical trials at a large university medical center 93%
- Quantitative bias analysis for mismeasured variables in health research: a review of software tools 93%
Similar papers in this journal
- Analysis of clinical trial registry entry histories using the novel R package cthist 96%
- Exploring scalable assessment methods for terminated trials in ClinicalTrials.gov: A cohort analysis of German and Californian trials 94%
- COVID-19-related research data availability and quality according to the FAIR principles: A meta-research study 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.